Jatenzo Cost in Michigan: Pricing, Insurance, and Savings Options (2026)

What Jatenzo Actually Costs at Michigan Pharmacies

The average cash-pay price for Jatenzo at Michigan retail pharmacies sits at roughly $900 per month in 2026, matching the manufacturer list price set by Tolmar Pharmaceuticals. That figure applies to a standard 30-day supply of oral testosterone undecanoate capsules taken twice daily with food.

Prices can shift depending on the specific pharmacy. Major chains like CVS, Walgreens, and Meijer pharmacies across Michigan tend to cluster near the list price for brand-name Jatenzo, though independent pharmacies may show slight variation. No FDA-approved generic version of oral testosterone undecanoate exists as of May 2026, which keeps competitive pricing pressure low [1].

The $900 figure represents what an uninsured or out-of-network patient would pay without any discount program. Jatenzo received FDA approval in March 2019 as the first oral testosterone undecanoate product for adult males with hypogonadism due to certain medical conditions [2]. The key trial by Swerdloff et al. (2020) demonstrated that 87% of patients achieved testosterone levels within the normal range (300-1,100 ng/dL) at the 237 mg twice-daily dose, confirming the drug's efficacy as an alternative to injectable and topical testosterone formulations [1].

For patients paying out of pocket, that monthly cost adds up to $10,800 annually. This makes cost mitigation strategies (insurance coverage, savings cards, or compounded alternatives) a practical necessity for most Michigan patients on long-term TRT.

Michigan Medicaid Coverage for Jatenzo

Michigan Medicaid does cover Jatenzo, but requires prior authorization (PA) before filling. The PA process confirms a documented diagnosis of male hypogonadism supported by two morning serum testosterone levels below 300 ng/dL, consistent with Endocrine Society Clinical Practice Guidelines [3].

Prescribers must submit the PA request through Michigan's Medicaid pharmacy benefit manager. Typical turnaround runs 24 to 72 hours. The PA documentation generally requires: a confirmed ICD-10 code for male hypogonadism (E29.1), laboratory values showing low testosterone on at least two occasions, and evidence that the prescribing indication aligns with FDA-approved use (hypogonadism due to specific medical conditions, not age-related decline alone) [2].

Once approved, Michigan Medicaid beneficiaries pay minimal or zero copay for Jatenzo depending on their specific plan tier. PA renewals are typically required annually. Denials can be appealed through Michigan's standard Medicaid appeals process, and prescribers should document why oral testosterone undecanoate is medically necessary over lower-cost alternatives such as injectable testosterone cypionate (which costs Michigan Medicaid roughly $30-50 per month).

Dr. Bradley Anawalt, an endocrinologist at the University of Washington and contributor to the Endocrine Society guidelines, has noted: "Oral testosterone undecanoate fills an important gap for patients who cannot use or tolerate injectable or transdermal testosterone, particularly those with needle phobia or skin reactions to gels" [3].

Commercial Insurance Coverage Across Michigan

Coverage for Jatenzo among Michigan's commercial insurers is inconsistent. Some plans place it on specialty tiers with higher copays, while others exclude it entirely or require step therapy through injectable testosterone first.

Blue Cross Blue Shield of Michigan (BCBSM), the state's largest insurer, generally requires prior authorization and may mandate a trial of at least one injectable or topical testosterone formulation before covering Jatenzo. Priority Health, another major Michigan insurer, follows a similar step-therapy model. HAP (Health Alliance Plan) policies vary by employer group.

Patients with commercial insurance can expect copays ranging from $50 to $300 per month after PA approval, depending on their plan's formulary tier placement. Self-funded employer plans (ERISA plans) set their own formulary rules and may differ from the insurer's standard commercial formulary.

To check your specific coverage, contact your insurer's pharmacy benefits line with Jatenzo's NDC number and your plan ID before filling the prescription. Your prescriber's office can also run a real-time benefits check through most e-prescribing platforms to show your expected out-of-pocket cost before you commit.

How the Tolmar Savings Card Works in Michigan

Tolmar Pharmaceuticals offers a manufacturer savings card for Jatenzo that can reduce the monthly out-of-pocket cost for eligible commercially insured patients. The card is accepted at Michigan pharmacies that process commercial prescription claims.

Eligibility requirements are straightforward. Patients must have commercial (private) insurance. Those covered by government-funded programs (Medicaid, Medicare, Tricare, VA benefits) are excluded from the savings card, as federal anti-kickback statutes prohibit manufacturer copay assistance for government-insured prescriptions [4].

Eligible patients can typically reduce their copay to as low as $0 to $75 per month, though the exact savings depend on the patient's insurance plan and the card's current terms. The savings card has a maximum annual benefit cap (check Tolmar's current program terms, as these change periodically). Patients activate the card online or through their prescriber's office, and the pharmacy processes it as a secondary payer at the point of sale.

One practical consideration: savings cards do not count toward your plan's deductible or out-of-pocket maximum. This means if your insurer requires a deductible before covering Jatenzo, the savings card payments will not help you meet that threshold. Patients with high-deductible health plans should factor this into their annual cost planning.

Compounded Oral Testosterone Undecanoate in Michigan

Licensed 503A compounding pharmacies in Michigan can legally prepare oral testosterone undecanoate formulations based on a valid patient-specific prescription. This is a regulated pathway under both federal law (Drug Quality and Security Act, 2013) and Michigan's Board of Pharmacy compounding rules [5].

The cost advantage is significant. Compounded oral testosterone undecanoate from a 503A pharmacy in Michigan may cost substantially less than brand-name Jatenzo, though exact pricing varies by pharmacy and formulation. Some Michigan compounding pharmacies offer 30-day supplies for a fraction of the brand price.

There are important distinctions between compounded and brand-name products. Compounded formulations are not FDA-approved, do not undergo the same bioequivalence testing as Jatenzo, and may differ in capsule composition, lipid-based excipients, or absorption characteristics. The Swerdloff et al. trial data applies specifically to Jatenzo's proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation, not to compounded versions [1].

Michigan patients considering compounded oral testosterone undecanoate should verify that their pharmacy holds a valid Michigan Board of Pharmacy compounding license and complies with USP <795> standards for non-sterile compounding [6]. Ask whether the pharmacy conducts third-party potency and purity testing on its compounded testosterone products. Dr. Adrian Dobs, an endocrinologist at Johns Hopkins who has studied testosterone formulations, has stated: "Patients choosing compounded testosterone products should understand that the pharmacokinetics may differ from the studied brand-name product, and monitoring of serum levels is especially important" [7].

503B outsourcing facilities can also supply oral testosterone undecanoate to Michigan prescribers, though these products are typically distributed to clinics rather than dispensed directly to patients at retail.

Telehealth Access to Jatenzo in Michigan

Michigan permits telehealth prescribing of Jatenzo. Physicians and qualified prescribers licensed in Michigan can evaluate patients via synchronous video or audio visits, diagnose hypogonadism based on symptoms and lab work, and prescribe oral testosterone undecanoate without an in-person visit [8].

Michigan's telehealth parity law (MCL 500.3476) requires insurers to cover telehealth-delivered services at the same rate as in-person visits, which means the evaluation itself should be covered at standard rates. The prescription can then be sent electronically to any Michigan pharmacy.

Practical steps for Michigan patients seeking Jatenzo via telehealth:

1. Obtain two morning fasting testosterone blood draws (labs can be ordered remotely and drawn at any Quest, Labcorp, or hospital lab in Michigan).
2. Schedule a telehealth evaluation with a licensed Michigan prescriber or a multi-state telehealth platform that includes Michigan licensure.
3. If total testosterone is below 300 ng/dL on both draws and symptoms are consistent with hypogonadism, the prescriber can write the Jatenzo prescription.
4. The e-prescription goes to your chosen Michigan pharmacy, and you or your prescriber's office initiates prior authorization if required by your insurer.

Telehealth platforms that specialize in men's hormone therapy often bundle the lab orders, consultation, and ongoing monitoring into a single fee structure. Compare these bundled costs against the combination of your PCP copay plus pharmacy costs to determine the most economical path.

Jatenzo vs. Other Testosterone Options: Michigan Pricing Context

Understanding Jatenzo's $900/month price point requires comparison to other testosterone replacement options available in Michigan.

Injectable testosterone cypionate (the most commonly prescribed TRT in the U.S.) costs roughly $30 to $80 per month at Michigan pharmacies for the generic version. Testosterone gel (AndroGel 1.62%) runs $500 to $700 per month for brand-name, with generic testosterone gel available for $50 to $150 per month. Testosterone pellets (Testopel) cost $500 to $1,500 per insertion every 3 to 6 months, depending on the number of pellets and the clinic's procedure fee [9].

Jatenzo's primary advantage is its oral route of administration. The Swerdloff et al. study showed mean steady-state testosterone concentrations (Cavg) of 489 ng/dL at the 237 mg twice-daily dose, with 87% of subjects achieving levels within the eugonadal range [1]. Unlike older oral testosterone formulations (methyltestosterone), oral testosterone undecanoate bypasses first-pass liver metabolism through lymphatic absorption, which the FDA determined posed an acceptable hepatotoxicity profile [2].

The clinical trade-off in Michigan is clear: patients pay a premium for the convenience of twice-daily oral dosing versus weekly or biweekly injections. For patients with needle phobia, occupational constraints on injection schedules, or adverse reactions to topical gels (skin irritation, transfer risk to household contacts), the premium may be justified. For patients comfortable with self-injection, generic testosterone cypionate offers the same therapeutic goal at roughly one-twentieth the monthly cost.

Strategies to Lower Your Jatenzo Cost in Michigan

Michigan patients have several concrete options to reduce Jatenzo expenses beyond standard insurance coverage.

Tolmar savings card. The first step for any commercially insured patient. Apply before filling your first prescription. The card can drop your copay substantially and takes minutes to activate.

Pharmacy shopping. Michigan has no law prohibiting price variation between pharmacies for the same brand-name drug. Call at least three pharmacies (include one independent pharmacy and one large chain) to compare Jatenzo pricing. Some pharmacy discount aggregators show real-time Jatenzo pricing across Michigan zip codes.

Prior authorization appeals. If your insurer denies PA, file a formal appeal. Include your prescriber's letter explaining why oral testosterone undecanoate is medically necessary for your case (document prior treatment failures, contraindications to alternatives, or adherence barriers with other formulations). Michigan's insurance appeal process allows external review by an independent reviewer if the internal appeal is denied [10].

Compounded oral testosterone undecanoate. If brand-name Jatenzo is financially prohibitive and your prescriber agrees, a compounded version from a licensed Michigan 503A pharmacy is a legal alternative. Discuss the trade-offs (lack of FDA approval, potential pharmacokinetic differences) with your prescriber.

Patient assistance programs. Tolmar's patient assistance program may cover Jatenzo at no cost for uninsured patients who meet income eligibility criteria. Contact Tolmar's patient services line directly for current income thresholds and application requirements.

Flexible spending or health savings accounts. Jatenzo is a qualifying prescription expense for FSA and HSA accounts. Paying with pre-tax dollars effectively reduces your cost by your marginal tax rate (22% to 37% for most Michigan households).

Monitoring Costs to Factor In

The prescription cost is not the only expense. TRT with Jatenzo requires ongoing lab monitoring that adds to total annual cost. The Endocrine Society recommends checking serum testosterone levels 3 to 6 hours after the morning dose (to capture peak absorption), along with hematocrit, PSA, and liver function tests at baseline, 3 months, 6 months, and annually thereafter [3].

A basic TRT monitoring panel (total testosterone, free testosterone, hematocrit, CBC, CMP, lipid panel, PSA) costs $100 to $300 per draw at Michigan labs without insurance. Most Michigan insurers cover these labs at standard rates when ordered with an appropriate diagnosis code. Quest Diagnostics and Labcorp both have extensive Michigan locations and offer direct-to-consumer lab pricing for uninsured patients.

The FDA label for Jatenzo specifically notes the potential for dose-dependent increases in systolic blood pressure (mean increase of 3-5 mmHg at the 396 mg dose in clinical trials) and recommends blood pressure monitoring during treatment [2]. Michigan patients should factor in periodic blood pressure checks, which are typically included in follow-up visits but represent an additional touchpoint in their care schedule.

Annual total cost of Jatenzo therapy in Michigan, including the medication, monitoring labs, and prescriber visits, ranges from approximately $11,000 to $13,000 without any insurance or discount assistance, and from $600 to $4,500 with typical commercial insurance coverage and savings card use.